Edwards Lifesciences Corporation
Symbol: EW
NYSE
85.25
USDDzisiejsza cena rynkowa
36.2756
Wskaźnik P/E
2.3277
Wskaźnik PEG
51.37B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Edwards Lifesciences Corporation (EW) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 6715.3 | 1644.5 | 1215.3 | 1466.8 | |||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1894 | 500.5 | 446.3 | 604 | |||||||||||||||||||||||||
balance-sheet.row.net-receivables | 3332.8 | 836.9 | 699.1 | 664.9 | |||||||||||||||||||||||||
balance-sheet.row.inventory | 4388.1 | 1168.2 | 875.5 | 726.7 | |||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 1081.2 | 239.3 | 195.9 | 237.1 | |||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 15920.7 | 4035.7 | 3095.8 | 3180.7 | |||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 7229 | 1843.4 | 1725.1 | 1638.7 | |||||||||||||||||||||||||
balance-sheet.row.goodwill | 5103.2 | 1253.5 | 1164.3 | 1167.9 | |||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1736.4 | 428.4 | 285.2 | 323.6 | |||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 6839.6 | 1681.9 | 1449.5 | 1491.5 | |||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2600.3 | 583.9 | 1239 | 1834.2 | |||||||||||||||||||||||||
balance-sheet.row.tax-assets | 2793.9 | 754.6 | 484 | 246.7 | |||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 2090.8 | 463.7 | 299.1 | 110.8 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 21553.6 | 5327.5 | 5196.7 | 5321.9 | |||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-assets | 37474.3 | 9363.2 | 8292.5 | 8502.6 | |||||||||||||||||||||||||
balance-sheet.row.account-payables | 1671 | 201.4 | 201.9 | 204.5 | |||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 98.3 | 24.9 | 25.5 | 25.5 | |||||||||||||||||||||||||
balance-sheet.row.tax-payables | 440.9 | 122.3 | 96.2 | 99.5 | |||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 2594.2 | 670 | 665.8 | 664.8 | |||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 3448.7 | 15.2 | 311 | 3.9 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5692.6 | 1448.4 | 1463.4 | 1634.4 | |||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 357.2 | 97.9 | 95 | 94.6 | |||||||||||||||||||||||||
balance-sheet.row.total-liab | 10394.9 | 2643.8 | 2485.8 | 2666.7 | |||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.common-stock | 2601.3 | 650.5 | 646.3 | 642 | |||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 35196.8 | 8992.4 | 7590 | 6068.1 | |||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -981.7 | -242.8 | -254.9 | -157.7 | |||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -10015.3 | -2750.1 | -2174.7 | -716.5 | |||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 26801.1 | 6650 | 5806.7 | 5835.9 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 37474.3 | 9363.2 | 8292.5 | 8502.6 | |||||||||||||||||||||||||
balance-sheet.row.minority-interest | 278.3 | 69.4 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-equity | 27079.4 | 6719.4 | 5806.7 | 5835.9 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 37474.3 | - | - | - | |||||||||||||||||||||||||
Total Investments | 4494.3 | 1084.4 | 1685.3 | 2438.2 | |||||||||||||||||||||||||
balance-sheet.row.total-debt | 2769.7 | 694.9 | 691.3 | 690.3 | |||||||||||||||||||||||||
balance-sheet.row.net-debt | -2051.6 | -449.1 | -77.7 | -172.5 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 1409.9 | 1399.4 | 1521.9 | 1503.1 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 148.2 | 144.9 | 139.6 | 134.8 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -256.1 | -272.1 | -254.5 | -41.4 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 145.1 | 139.4 | 126.8 | 109.3 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -928.7 | -526.3 | -421.4 | 145.3 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | -348.9 | -141.2 | -84.1 | -112.4 | |||||||||||||||||||||||||
cash-flows.row.inventory | -325.7 | -289 | -213.4 | 19 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 102.1 | 146 | -21.4 | 195.2 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | -378.1 | -242.1 | -102.5 | 43.5 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 9.8 | 10.5 | 105.8 | -119 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 528.2 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -290.1 | -266.3 | -264.8 | -329.8 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 149.2 | -95.2 | 0 | 329.8 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -88.2 | -105.5 | -778.9 | -1892.4 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 618.5 | 715.8 | 1359.1 | 529.2 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -153 | -75 | -63.1 | -359.3 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 236.4 | 173.8 | 252.3 | -1722.5 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | -0.3 | -0.3 | -0.2 | -7 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 190.1 | 169.9 | 146.4 | 158.6 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -630.5 | -879.6 | -1727.1 | -512.8 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -169.9 | -146.4 | -158.6 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 30.9 | 168.9 | 142.8 | 163.5 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -442.7 | -711 | -1584.5 | -356.3 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 30.7 | 16.8 | 19.2 | 13.9 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 352.6 | 375.4 | -94.8 | -332.8 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4838.4 | 1148 | 772.6 | 867.4 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4485.8 | 772.6 | 867.4 | 1200.2 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 528.2 | 895.8 | 1218.2 | 1732.1 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -290.1 | -266.3 | -264.8 | -329.8 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 238.1 | 629.5 | 953.4 | 1402.3 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 6143.4 | 6004.8 | 5382.4 | 5232.5 | |||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 1434.5 | 1379.8 | 1080.4 | 1248.9 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit | 4708.9 | 4625 | 4302 | 3983.6 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.research-development | 1095.8 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0.4 | 3.4 | 2.6 | 12.7 | |||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 2974 | 2895.2 | 2512.8 | 2396.8 | |||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 4408.5 | 4275 | 3593.2 | 3645.7 | |||||||||||||||||||||||||
income-statement-row.row.interest-income | 30.5 | 67.2 | 35.5 | 17.4 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 27.8 | 17.6 | 19.2 | 18.4 | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -167 | -181.3 | 18.9 | 353.5 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.4 | 3.4 | 2.6 | 12.7 | |||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -167 | -181.3 | 18.9 | 353.5 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 27.8 | 17.6 | 19.2 | 18.4 | |||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 78 | 144.9 | 81.4 | 134.8 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1886.7 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.operating-income | 1583.4 | 1534.1 | 1748.5 | 1348.5 | |||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 1608.9 | 1598.1 | 1767.4 | 1702 | |||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 199 | 198.7 | 245.5 | 198.9 | |||||||||||||||||||||||||
income-statement-row.row.net-income | 1413.8 | 1402.4 | 1521.9 | 1503.1 |
Często zadawane pytania
Ile wynosi Edwards Lifesciences Corporation (EW) aktywów ogółem?
Edwards Lifesciences Corporation (EW) całkowite aktywa to 9363200000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 3132300000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.766.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.396.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.230.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.258.
Co to jest Edwards Lifesciences Corporation (EW) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 1402400000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 694900000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 2895200000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 1224600000.000.